Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ostrowski

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1990
Problems in the management of testicular seminoma associated with a horseshoe kidneyS A Elyan, D H Reed, M J Ostrowski, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinomaP A Lawton, M F Spittle, M J Ostrowski, et al.
Clinical Oncology|June 1, 1980
Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy GroupM F Spittle, T D Bates, G Kitchen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapyJ Shamash, R T Oliver, J Ong, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancerM F Spittle, B T Hill, M J Ostrowski, et al.
Urology|March 19, 2004
Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapyR T D Oliver, J Ong, J Shamash, et al.
Clinical Oncology|March 1, 1978
Anti-oestrogen therapy for breast cancer--a report on 300 patients treated with tamoxifenH W Ward, K Arthur, A J Banks, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1986
Adjuvant chemotherapy in the treatment of breast cancer: results of a multicentre studyM F Spittle, M J Ostrowski, B T Hill, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?R T Oliver, P M Edmonds, J Y Ong, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1990
Problems in the management of testicular seminoma associated with a horseshoe kidneyS A Elyan, D H Reed, M J Ostrowski, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinomaP A Lawton, M F Spittle, M J Ostrowski, et al.
Clinical Oncology|June 1, 1980
Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy GroupM F Spittle, T D Bates, G Kitchen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapyJ Shamash, R T Oliver, J Ong, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancerM F Spittle, B T Hill, M J Ostrowski, et al.
Urology|March 19, 2004
Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapyR T D Oliver, J Ong, J Shamash, et al.
Clinical Oncology|March 1, 1978
Anti-oestrogen therapy for breast cancer--a report on 300 patients treated with tamoxifenH W Ward, K Arthur, A J Banks, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1986
Adjuvant chemotherapy in the treatment of breast cancer: results of a multicentre studyM F Spittle, M J Ostrowski, B T Hill, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?R T Oliver, P M Edmonds, J Y Ong, et al.
Pageof 3